Medicure (MCUJF) Cash from Discontinued Operations (2009 - 2017)
Medicure's (MCUJF) quarterly Cash from Discontinued Operations came in at 168683.19 in Q3 2017, down 155.56% quarter-over-quarter from 303623.9 in Q1 2011.
Medicure (MCUJF) Cash from Discontinued Operations (2009 - 2017) Analysis & Trends
Medicure's Cash from Discontinued Operations history runs 4 years deep, the most recent figure standing at 168683.19 for Q3 2017.
- On a quarterly basis, Cash from Discontinued Operations changed N/A year-over-year to 168683.19 in Q3 2017; TTM through Sep 2017 was 3409634.18, a N/A change from a year earlier, with the FY2016 full-year figure at 20228745.63, changed N/A from the prior year.
- Cash from Discontinued Operations slipped to 168683.19 in Q3 2017 per MCUJF's latest filing, from 303623.9 in the prior quarter.
- Across five years, Cash from Discontinued Operations topped out at 168683.19 in Q3 2017 and bottomed at 168683.19 in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | -168,683.19 |
| Sep 30, 2017 | -168,683.19 |
| Feb 28, 2011 | 303,623.90 |
| Feb 28, 2011 | 303,623.90 |
| Feb 28, 2010 | 297,270.86 |
| Feb 28, 2010 | 297,270.86 |
| Feb 28, 2009 | 2.98 Mn |
| Feb 28, 2009 | 2.98 Mn |